glp 1 drugs for binge eating disorder GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Experts express alarm that GLP-1
Description
Pharmacol Rep (2016) 68(2):32937
There were no statistically significant differences in post-hoc testing
Rise of Dual and Triple Agonists: Beyond GLP-1, newer drugs target GIP and glucagon receptors for enhanced efficacy (e.g., Tirzepatide, Retatrutide)
Both studies reported almost no change in LVEF between the placebo and treatment groups (Table 3)
[DOI] [PubMed] [Google Scholar] 20.Docimo S., Jr., Svestka M
Lets break down everything you need to know to get started
